American Portfolios Advisors Zai Lab LTD Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Zai Lab LTD stock. As of the latest transaction made, American Portfolios Advisors holds 14 shares of ZLAB stock, worth $433. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14Holding current value
$433% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ZLAB
# of Institutions
146Shares Held
53MCall Options Held
103KPut Options Held
439K-
Wellington Management Group LLP Boston, MA6.66MShares$206 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.57MShares$203 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$199 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$98.1 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$77.7 Million1.07% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.03B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...